Literature DB >> 7673250

Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus.

Q Dang1, D Walker, S Taylor, C Allan, P Chin, J Fan, J Taylor.   

Abstract

The specificity of expression in the liver of the human apolipoprotein (apo) E/C-I gene locus is determined by a hepatic control region (HCR) that is located 15 kilobases downstream of the apoE gene. DNase I footprint studies of this sequence using nuclear extracts identified a region of the HCR that is enriched in nuclear protein-binding sites. Nuclease analysis of chromatin revealed liver-specific DNase I-hypersensitive sites that were associated with this region, and additional liver-specific nuclease-sensitive sites associated with the apoE gene were identified. The HCR domain has a limited binding affinity for the nuclear scaffold. The specific domain required for liver expression was tested by ligating subfragments of the HCR to the apoE gene and examining their activity in transgenic mice. A segment of 319 nucleotides that contained several potential regulatory sequences was required for full activity of liver-specific transcription with shorter segments yielding much lower levels of expression in the liver. All constructs that contained a fully active HCR were expressed in approximately a copy-dependent manner, suggesting that transgene expression was independent of integration position. Taken together, the properties of the HCR are consistent with its function as a locus control region for the liver-specific expression of the apoE gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673250     DOI: 10.1074/jbc.270.38.22577

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression.

Authors:  X Wang; W Zeng; M Murakawa; M W Freeman; B Seed
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Locus control regions.

Authors:  Qiliang Li; Kenneth R Peterson; Xiangdong Fang; George Stamatoyannopoulos
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

3.  Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.

Authors:  N S Shachter; T Ebara; R Ramakrishnan; G Steiner; J L Breslow; H N Ginsberg; J D Smith
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Hepatocyte nuclear factor 4α and downstream secreted phospholipase A2 GXIIB regulate production of infectious hepatitis C virus.

Authors:  Xinlei Li; Hanfang Jiang; Linbing Qu; Wenxia Yao; Hua Cai; Ling Chen; Tao Peng
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.

Authors:  G P Hayhurst; Y H Lee; G Lambert; J M Ward; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

6.  Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain.

Authors:  S Grehan; E Tse; J M Taylor
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 7.  A review of alcohol-pathogen interactions: New insights into combined disease pathomechanisms.

Authors:  Natalia A Osna; Moses New-Aaron; Raghubendra S Dagur; Paul Thomes; Liz Simon; Danielle Levitt; Patrick McTernan; Patricia E Molina; Hye Yeon Choi; Keigo Machida; Kenneth E Sherman; Antonio Riva; Sandra Phillips; Shilpa Chokshi; Kusum K Kharbanda; Steven Weinman; Murali Ganesan
Journal:  Alcohol Clin Exp Res       Date:  2022-02-06       Impact factor: 3.455

8.  Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis.

Authors:  V Ratziu; A Lalazar; L Wong; Q Dang; C Collins; E Shaulian; S Jensen; S L Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Construction of minicircle DNA vectors capable of correcting familial hypercholesterolemia phenotype in a LDLR-deficient mouse model.

Authors:  X Hou; R Jiao; X Guo; T Wang; P Chen; D Wang; Y Chen; C-Y He; Z-Y Chen
Journal:  Gene Ther       Date:  2016-04-19       Impact factor: 5.250

10.  Massively parallel functional dissection of mammalian enhancers in vivo.

Authors:  Rupali P Patwardhan; Joseph B Hiatt; Daniela M Witten; Mee J Kim; Robin P Smith; Dalit May; Choli Lee; Jennifer M Andrie; Su-In Lee; Gregory M Cooper; Nadav Ahituv; Len A Pennacchio; Jay Shendure
Journal:  Nat Biotechnol       Date:  2012-02-26       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.